Cross Country Healthcare, Inc. (CCRN) Reports In-Line Q1 EPS, Posts Q2 Guidance
Tweet
Share
E-mailGet Alerts CCRN Hot Sheet
Price: $13.25 --0%
Financial Fact:
Total operating expenses: 205.66M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total operating expenses: 205.66M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cross Country Healthcare, Inc. (NASDAQ: CCRN) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $122 million versus the consensus estimate of $120.07 million.
Cross Country Healthcare, Inc. sees Q2 2011 EPS of $0.02-$0.04, versus the consensus of $0.04. Cross Country Healthcare, Inc. sees Q2 2011 revenue of $126-$128 million, versus the consensus of $122.63 million.
Cross Country Healthcare, Inc. sees Q2 2011 EPS of $0.02-$0.04, versus the consensus of $0.04. Cross Country Healthcare, Inc. sees Q2 2011 revenue of $126-$128 million, versus the consensus of $122.63 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Torrid Holdings Inc. (CURV) Tops Q2 EPS by 8c; Offers Guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
